Information about EquiVita Genetics
My details
*
*
*

EquiVita Genetics (SRL)

Company information

Status
Active

Enterprise number

BE0772.385.165

VAT liability
Yes
Established
09-08-2021
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from EquiVita Genetics

2024 2023 2022
Profit/Loss -137,373 12 % -155,884 -5701 % -2,687
Equity -39,744 -141 % 97,629 -61 % 253,513
Gross margin -60,515 35 % -92,441 -4933 % -1,837
Employees 0.9

Publications from EquiVita Genetics

Date Publication
06-01-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Miscellaneous - Capital - Shares (NL)
11-08-2021 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of EquiVita Genetics?
The VAT number of EquiVita Genetics is BE 0772.385.165.
Wat is the PEPPOL ID of EquiVita Genetics?
The PEPPOL ID of EquiVita Genetics is 0208:0772385165. Log in or start a free trial to see the full overview.
When was EquiVita Genetics founded?
EquiVita Genetics was founded on 09-08-2021.
What is the address of EquiVita Genetics?
The current registered office of EquiVita Genetics is located at Tongersesteenweg 13A/2, 3720 Hasselt.
When was the last time EquiVita Genetics filed their annual financial statements?
The most recent financial statements of EquiVita Genetics were filed on 04-09-2025.
How many employees does EquiVita Genetics have?
There are currently no employees working at EquiVita Genetics or no workforce information is available.
What is the annual turnover of EquiVita Genetics?
At the time of its most recent financial statements, EquiVita Genetics did not publish any turnover figures. EquiVita Genetics reported a gross margin of -€60,515.03.